revascularization

(redirected from Myocardial revascularization)
Also found in: Dictionary, Acronyms.

revascularization

 [re-vas″ku-lah-rĭ-za´shun]
1. the restoration of blood supply, as after a wound.
2. the restoration of an adequate blood supply to a part by means of a blood vessel graft, as in aortocoronary bypass.

re·vas·cu·lar·i·za·tion

(rē-vas'kyū-lăr-i-zā'shŭn),
Reestablishment of blood supply to a part.

revascularization

Vascular disease A surgical procedure in which compromised or stenosed blood vessels are bypassed to treat ischemia; revascularization is the treatment of choice for Pts subsequently found to have abnormal ventricular function and extensive CAD. See CABG.

re·vas·cu·lar·i·za·tion

(rē-vas'kyū-lăr-ī-zā'shŭn)
Reestablishment of blood supply to a part.

re·vas·cu·lar·i·za·tion

(rē-vas'kyū-lăr-ī-zā'shŭn)
Reestablishment of blood supply to a body part.
References in periodicals archive ?
Since the moment they have been introduced, temporary intracoronary stents have been used for classic CABGs and myocardial revascularization on a beating heart.
KEY WORDS: Myocardial Revascularization; Stress testing; Coronary Artery; Coronary Artery Disease.
In these patients, the IMA can be the main source of collateral circulation to the femoral arteries and its use in myocardial revascularization is associated with acute lower limbs ischemia.
Post-myocardial infarction cardiogenic shock (CS) still carries a very poor prognosis despite of the rapid management using effective strategies of myocardial revascularization. (1) It has been shown to be a strong independent predictor of early- and-late mortality.
However, while DES have become the treatment of choice in the majority of PCI procedures with superior results even in ESRD patients due to lower rates of target lesion revascularization compared to BMS [36, 37], current European Guidelines for Myocardial revascularization recommend no universal use of DES in ESRD patients, as DES have not been shown to be of general advantage compared to BMS in these patients, and end stage renal disease is a risk factor for potentially fatal late stent thrombosis [38].
In this subpopulation, myocardial revascularization is often performed to ameliorate ischemic symptoms, improve LV performance, and prevent future ischemic events [1, 2].
Surgical myocardial revascularization had an ascending evolution during the past five decades.
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI).
Surgeons may be reluctant and cautious about using internal thoracic artery as a site of intervention for myocardial revascularization in patients with a history of thoracic radiotherapy.
Also standard myocardial revascularization with Cardiopulmonary Bypass (CPB) and aortic cross clamping has potential deleterious effects on neoplastic patients, enhancing the systemic inflammatory response and attenuating the immune response (3,4).
The role of ascorbic acid in the prevention of atrial fibrillation after elective on pump myocardial revascularization surgery: a single center experience pilot study.

Full browser ?